Combined photodynamic therapy and intravitreal bevacizumab as treatment for nonresponsive myopic choroidal neovascularization

Combined photodynamic therapy and intravitreal bevacizumab as treatment for nonresponsive myopic choroidal neovascularization

Bibliographic Details
Main Author:	Jay Kumar Chhablani
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2010-01-01
Series:	Oman Journal of Ophthalmology
Online Access:	http://www.ojoonline.org/article.asp?issn=0974-620X;year=2010;volume=3;issue=3;spage=159;epage=160;aulast=Chhablani

Similar Items

Intravitreal aflibercept versus bevacizumab for treatment of myopic choroidal neovascularization
by: Jia-Kang Wang, et al.
Published: (2018-09-01)

Combined photodynamic therapy and intravitreal ranibizumab as treatment for extrafoveal choroidal neovascularization associated with age-related macular degeneration
by: Jay Kumar Chhablani
Published: (2010-01-01)

Combined therapy with bevacizumab and photodynamic therapy for myopic choroidal neovascularization:A one-year follow-up controlled study
by: Sandro Saviano, et al.
Published: (2014-04-01)

Combination photodynamic therapy and bevacizumab for choroidal neovascularization associated with toxoplasmosis
by: Rishi Pukhraj, et al.
Published: (2011-01-01)

Combined photodynamic therapy and intravitreal ranibizumab as primary treatment for choroidal neovascularization associated with age-related macular degeneration in an Indian patient
by: Rishi Pukhraj, et al.
Published: (2008-01-01)

Single intravitreal ranibizumab for myopic choroidal neovascularization
by: Shatriah I, et al.
Published: (2011-08-01)

Combination of photodynamic therapy with intravitreal bevacizumab for post-peribulbar anesthesia (penetrating trauma)-persistent choroidal neovascular membrane
by: Shah Nikunj, et al.
Published: (2008-01-01)

Combined intravitreal bevacizumab and photodynamic therapy with vertiporfin for management of choroidal neovascularization secondary to age-related macular degeneration
by: Mamdouh M Kabeel, et al.
Published: (2008-03-01)

Photodynamic monotherapy or combination treatment with intravitreal triamcinolone acetonide, bevacizumab or ranibizumab for choroidal neovascularization associated with pathological myopia
by: Pukhraj Rishi, et al.
Published: (2011-01-01)

Effect of photodynamic therapy combined with intravitreal injection of Lucentis therapy on choroidal neovascularization
by: Yan-Mei Su
Published: (2016-03-01)

Combination therapy of intravitreal triamcinolone and photodynamic therapy with verteporfin for subfoveal choroidal neovascularization
by: Hussain Nazimul, et al.
Published: (2006-01-01)

Choroidal osteoma with choroidal neovascular membrane: Successful treatment with intravitreal bevacizumab
by: Neeraj Pandey, et al.
Published: (2010-09-01)

Predictors of visual outcome in eyes with choroidal neovascularization secondary to age related macular degeneration treated with intravitreal bevacizumab monotherapy
by: Jay Chhablani
Published: (2013-02-01)

Result of intravitreal aflibercept injection for myopic choroidal neovascularization
by: Shih-Lin Chen, et al.
Published: (2021-09-01)

Intravitreal bevacizumab monotherapy for treatment-naïve polypoidal choroidal vasculopathy
by: Jay Kumar Chhablani, et al.
Published: (2013-01-01)

Intravitreal bevacizumab monotherapy for treatment-naive polypoidal choroidal vasculopathy
by: Jay Kumar Chhablani, et al.
Published: (2014-01-01)

Photodynamic Therapy and Bevacizumab Combination for Polypoidal Choroidal Vasculopathy Refractory to Intravitreal Ranibizumab
by: Zeynep Alkin, et al.
Published: (2016-12-01)

Treatment of myopic choroidal neovascularization with intravitreal ranibizumab injections: the role of age
by: Karagiannis D, et al.
Published: (2017-06-01)

Intravitreal bevacizumab for management of choroidal osteoma without choroidal neovascularization
by: Farhad Fazel Najafabadi, et al.
Published: (2015-01-01)

Combination therapy of low-fluence photodynamic therapy and intravitreal ranibizumab for choroidal neovascular membrane in choroidal osteoma
by: Rodney J Morris, et al.
Published: (2011-01-01)

Intravitreal bevacizumab for treatment of choroidal neovascularization associated with osteogenesis imperfecta
by: Pukhraj Rishi, et al.
Published: (2012-01-01)

Choroideremia associated with choroidal neovascularization treated with intravitreal bevacizumab
by: Palejwala NV, et al.
Published: (2014-09-01)

Verteporfin photodynamic therapy combined with intravitreal triamcinolone for choroidal neovascularization due to angioid streaks
by: Alfredo Pece, et al.
Published: (2010-05-01)

Factors affecting visual outcome of myopic choroidal neovascularization treated with verteporfin photodynamic therapy
by: Tock-Han Lim, et al.
Published: (2013-06-01)

Successful management of choroidal neovascular membrane secondary to choroidal osteoma with intravitreal bevacizumab
by: Brijesh Takkar, et al.
Published: (2017-04-01)

Long-term success of intravitreal bevacizumab for choroidal neovascularization associated with choroidal osteoma
by: Kubota-Taniai M, et al.
Published: (2011-07-01)

Intravitreal bevacizumab in choroidal neovascularization associated with Best′s vitelliform dystrophy
by: Subrata Mandal, et al.
Published: (2011-01-01)

Intravitreal bevacizumab for parafoveal telangiectasia-associated choroidal neovascular membrane
by: Shanmugam Mahesh, et al.
Published: (2007-01-01)

Intravitreal bevacizumab (Avastin) in choroidal neovascular membrane in angioid streaks
by: Sachdev Nishant, et al.
Published: (2007-01-01)

Single-session photodynamic therapy combined with intravitreal bevacizumab and triamcinolone for neovascular age-related macular degeneration
by: Azarmina Mohsen, et al.
Published: (2007-06-01)

Combined photodynamic therapy and intravitreal bevacizumab as primary treatment for subretinal neovascularization associated with type 2 idiopathic macular telangiectasia
by: Rishi Pukhraj, et al.
Published: (2009-01-01)

Combined photodynamic therapy and intravitreal bevacizumab for idiopathic polypoidal choroidal vasculopathy: one-year follow-up
by: Mario R Romano, et al.
Published: (2010-10-01)

Only first intravitreal bevacizumab injection achieves statistically significant visual improvement in na&iuml;ve myopic choroidal neovascularization
by: Bergamini F, et al.
Published: (2012-11-01)

Comparison of intravitreal bevacizumab to photodynamic therapy for polypoidal choroidal vasculopathy: Short-term results
by: Mitamura Yoshinori, et al.
Published: (2010-01-01)

Comparison of intravitreal ziv-aflibercept and bevacizumab monotherapy in treatment-naive polypoidal choroidal vasculopathy
by: Sumit Randhir Singh, et al.
Published: (2019-01-01)

Therapeutic effect of photodynamic therapy and intravitreal injection with ranibizumab for choroidal neovascularization of pathologic myopia
by: Cong Zhang, et al.
Published: (2014-07-01)

Long-term outcomes of intravitreal injection of bevacizumab for choroidal neovascularization associated with choroidal osteoma
by: Yoshikawa T, et al.
Published: (2015-03-01)

Intravitreal Bevacizumab Injection Therapy in a Case with Choroidal Neovascular Membrane Secondary to Toxoplasmosis Retinochoroiditis
by: Sirel Gür Güngör, et al.
Published: (2014-05-01)

Disadvantages of photodynamic therapy for polypoidal choroidal vasculopathy
by: Chhablani Jay
Published: (2010-01-01)

Photodynamic therapy of subfoveal choroidal neovascularization
by: Georgijević Ana, et al.
Published: (2007-01-01)